Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
0.1291
-0.0031 (-2.34%)
At close: Dec 5, 2025, 4:00 PM EST
0.1269
-0.0022 (-1.70%)
After-hours: Dec 5, 2025, 7:57 PM EST
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $2.67 million as of December 5, 2025. Its market cap has decreased by -50.92% in one year.
Market Cap
2.67M
Enterprise Value
-800.39K
1-Year Change
-50.92%
Ranking
Category
Stock Price
$0.13
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.17M to $2.67M, a decrease of -89.81%. That is a compound annual growth rate of -41.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.67M | -55.90% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.13% |
| Dec 30, 2022 | 7.82M | -59.16% |
| Dec 27, 2021 | 19.14M | -26.88% |
| Aug 16, 2021 | 26.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |